Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

National Institute of Allergy and Infectious Diseases (NIAID) · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
autoimmune lymphoproliferative syndrome, fas, hypersplenism, lymphoproliferation, interleukin-2 inducible t-cell kinase, soquelitinib, targeted treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 995361
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.